Osteoporosis

Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China

Denosumab (DMAB) Discontinuation and Switching in Glucocorticoid-Induced Osteoporosis (GIOP): a Pilot Study

Abaloparatide Before Total Knee Arthroplasty

Bone Health in Aging HIV Infected Women

Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients

Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip Replacement

Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women

Fracture (FX) Improvement With Teriparatide: FiX-IT Study

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy

The Effect of Vitamin K2 on Bone Turnover

Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)

Danish Osteoporosis Prevention Study

A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis

Denosumab Adherence Preference Satisfaction Study

Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis

Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)

A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.

Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Open Label Extension

A New Active Vitamin D, ED-71 for Osteoporosis

Calcium Supplementation in Postmenopausal Women

Open Label Extension Study of PREOS

Vitamin K and Bone Turnover in Postmenopausal Women

IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)

Romosozumab in Women With Chronic SCI

Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis

Efficacy and Safety of AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis.

Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis

Fructooligosaccharide and Calcium Absorption in Adolescent Girls

Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.

Study of NaQuinate in Healthy Volunteers

Assessment of Anti-RANKL Antibody in Post-menopausal Women

Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects

Study Evaluating Premarin and Bazedoxifene Potential Interaction

Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects

Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

Study Evaluating Bazedoxifene/CE in Postmenopausal Women

Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women

Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women

A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group

Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution